Secondary osteoporosis in patients with chronic obstructive lung disease

Secondary osteoporosis in patients with chronic obstructive lung disease

Osteoporosis (OP) is a progressive multifactorial systemic skeletal disease resulting from a loss of bone mass and damage of bone structure (microarchitectonics). Chronic obstructive pulmonary disease (COPD) and bronchial asthma (BA) are major contributors to the development of osteoporosis.

Библиографические подробности
Главные авторы:	N. L. Shaporova, V. I. Trofimov
Формат:	Статья
Язык:	Russian
Опубликовано:	Remedium Group LLC 2013-12-01
Серии:	Медицинский совет
Предметы:	остеопороз обструктивные заболевания легких препараты кальция и витамина d антиостеопоретические средства osteoporosis obstructive pulmonary disease calcium and vitamin d medications anti-osteoporotic medications
Online-ссылка:	https://www.med-sovet.pro/jour/article/view/1147

Схожие документы

Contribution of age and functional disorders into the formation of vitamin D deficiency
по: I. S. Dydykina, и др.
Опубликовано: (2016-12-01)

Drugs associated with drug-induced interstitial lung diseases
по: O. D. Ostroumova, и др.
Опубликовано: (2021-08-01)

Defitsit kal'tsiya vo vremya beremennosti
по: M Yu Sokolova
Опубликовано: (2004-10-01)

«POKAZATELI MINERAL'NOY PLOTNOSTI KOSTNOY TKANI I UROVEN' 25-GIDROKSIVITAMINA D SYVOROTKI KROVI U ZhENShchIN REPRODUKTIVNOGO VOZRASTA
по: T. L. KARONOVA
Опубликовано: (2011-12-01)

MOLEKULYaRNO-GENETIChESKIE MARKERY OSTEOPOROZA U ZhITELEY BLOKADNOGO LENINGRADA
по: O N Semenova, и др.
Опубликовано: (2011-08-01)

PATHOLOGY OF BONE TISSUE IN DISEASES OF THE GASTROINTESTINAL TRACT
по: N. K. Slohova, и др.
Опубликовано: (2015-06-01)

Budesonide in patients with obstructive pulmonary disease
по: N. N. Mescheryakova
Опубликовано: (2015-12-01)

Clinical and laboratory comparison in postmenopausal osteoporosis with normal and enhanced function of the parathyroid glands
по: K. A. Saveleva, и др.
Опубликовано: (2015-06-01)

БРОНХОЛЁГОЧНАЯ ДИСПЛАЗИЯ У ГЛУБОКО НЕДОНОШЕННЫХ МЛАДЕНЦЕВ И ОБЕСПЕЧЕННОСТЬ ВИТАМИНОМ D: ПЕРИНАТАЛЬНЫЕ ОСОБЕННОСТИ
по: L. N. Sinitsa, и др.
Опубликовано: (2022-03-01)

The influence of surgical menopause oncardiovascular and osteoporosis risk factors(clinical observations)
по: E. Yu. Maychuk, и др.
Опубликовано: (2011-04-01)

РОЛЬ МИНИИНВАЗИВНЫХ ВИДЕОТОРАКОСКОПИЧЕСКИХ ОПЕРАЦИЙ В ДИФФЕРЕНЦИАЛЬНОЙ ДИАГНОСТИКЕ ДИССЕМИНИРОВАННЫХ И ОЧАГОВЫХ ПРОЦЕССОВ В ЛЕГКИХ НЕЯСНОЙ ЭТИОЛОГИИ
по: А. А. Кyrylyuk, и др.
Опубликовано: (2017-07-01)

Modern methods of prevention and treatment of postmenopausal osteoporosis
по: T. N. Savchenko, и др.
Опубликовано: (2018-07-01)

The genome-wide analysis of the vitamin D receptor binding sites evidences a wide range of potential therapeutic applications of vitamin D
по: O. A. Gromova, и др.
Опубликовано: (2016-12-01)

Cardiovascular Impact of Calcium and Vitamin D Supplements: A Narrative Review
по: Fatima Zarzour, и др.
Опубликовано: (2023-02-01)

Whether to prescribe calcium and vitamin D: arguments pro and contra
по: N. V. Toroptsova
Опубликовано: (2013-12-01)

POSSIBILITIES AND PROSPECTS OF DOUBLE EFFECT DRUGS APPLICATION FOR SYSTEMIC OSTEOPOROSIS PHARMACOTHERAPY OF PATIENTS WITH BONE FRACTURES
по: A. Y. Kochish, и др.
Опубликовано: (2012-06-01)

Pathogenetic mechanisms of postmenopausal osteoporosis formation and their relationship with cardiovascular pathology
по: G. V. Poryadin, и др.
Опубликовано: (2022-04-01)

Is Weekly Supplementation of Vitamin D Favorable for Treatment of Osteoporosis in Postmenopausal Women?
по: Mehmet Şükrü Budak, и др.
Опубликовано: (2012-08-01)

Expert suggestion for osteoporosis management during the recent COVID-19 pandemic
по: Chinese Society of Endocrinology,Chinese Medical Association , et al
Опубликовано: (2022-04-01)

Comparison of Dietary Supplement Intake between Healthy Individuals and Osteoporosis Patients in Gorgan, Iran
по: Mehrdad Aghaei, и др.
Опубликовано: (2017-08-01)

PREVALENCE OF OSTEOPOROSIS AND HYPOVITAMINOSIS D AT SIRIRAJ METABOLIC BONE DISEASE CLINIC
по: AASIS UNNANUNTANA, и др.
Опубликовано: (2017-12-01)

EFFECT OF A 5-YEAR ALFACALCIDOL TREATMENT IN COMBINATION WITH CALCIUM CARBONATE ON BONE MINERAL DENSITY IN THE PRIMARY FORMS OF SYSTEMIC OSTEOPOROSIS IN MEN
по: S S Rodionova, и др.
Опубликовано: (2016-12-01)

Additional aspects of the prediction of postmenopausal osteoporosis
по: I S Zakharov, и др.
Опубликовано: (2015-10-01)

Health technology assessment: factors affecting the results
по: I. N. Kozhanova
Опубликовано: (2021-12-01)

Bronkhit u beremennykh
по: M M Shekhtman, и др.
Опубликовано: (2005-02-01)

PREVALENCE OF VITAMIN D DEFICIENCY IN PEOPLE OVER 50 YEARS OLD RESIDING IN REPUBLIC OF BASHKORTOSTAN IN PERIODS OF LOW INSOLATION
по: R Z Nurlygayanov, и др.
Опубликовано: (2012-12-01)

PREVALENCE AND RISK FACTORS OF LOW-ENERGY SKELETAL FRACTURES IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES. THE RESULTS OF A MULTICENTER STUDY OF THE RUSSIAN ASSOCIATION ON OSTEOPOROSIS GLUKOST
по: I A Baranova, и др.
Опубликовано: (2014-12-01)

Influence of selected food in the profilactice and treatment of osteoporosis
по: Rafał Gorzyński, и др.
Опубликовано: (2023-06-01)

Calcium and osteoporosis in old and very old patients with coronary artery disease
по: Svetlana V. Topolyanskaya, и др.
Опубликовано: (2023-02-01)

The experience of the parenteral form of ibandrinic acid administration in different clinical situations of treatment of postmenopausal osteoporosis
по: L. A. Marchenkova, и др.
Опубликовано: (2021-06-01)

Evaluation of adherence to calcium, vitamin D and drugs for osteoporosis in patients with low bone mineral density
по: Maksimović Marina, и др.
Опубликовано: (2017-01-01)

Лекарственно-индуцированные интерстициальные поражения легких
Опубликовано: (2016-12-01)

The metabolites of vitamin D: role in the diagnosis and in the therapy of vitamin-D-dependent pathologies
по: O. A. Gromova, и др.
Опубликовано: (2016-11-01)

The effect of cigarette smoking on the serum levels of calcium and 25 hydroxy vitamin D in patients with postmenopausal osteoporosis
по: Wu Lifang, и др.
Опубликовано: (2022-12-01)

Impact of the Requirement of Bone Mineral Density Evidence on Utilization of Anti-osteoporosis Medications, Clinical Outcome and Medical Expenditures of Patient With Hip Fracture in Taiwan
по: Chen-Yu Wang, и др.
Опубликовано: (2022-04-01)

Renaissance of Vitamin D. molecular biological, physiological and pharmacological aspects
по: G. Y. Schwarz
Опубликовано: (2015-12-01)

Glucocorticoid induced osteoporosis in neurological patients: prevention and treatment
по: K. V. Antonova, и др.
Опубликовано: (2017-09-01)

COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS
по: N. A. Karoli, и др.
Опубликовано: (2016-01-01)

Education and exercise program improves osteoporosis knowledge and changes calcium and vitamin D dietary intake in community dwelling elderly
по: Ki-Soo Park, и др.
Опубликовано: (2017-12-01)

Knowledge Level and Awareness About Calcium Deficiency, Vitamin D Deficiency and Osteoporosis Among Physical Therapy and Rehabilitation School Students
по: Fatmanur Aybala Koçak, и др.
Опубликовано: (2020-04-01)